Medline ® Abstract for Reference 42
of 'Effect of antidepressants on suicide risk in children and adolescents'
ACNP Task Force report on SSRIs and suicidal behavior in youth.
Mann JJ, Emslie G, Baldessarini RJ, Beardslee W, Fawcett JA, Goodwin FK, Leon AC, Meltzer HY, Ryan ND, Shaffer D, Wagner KD
This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.
Columbia University/New York State Psychiatric Institute, New York, NY 10032, USA. email@example.com